BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• FDA

  NanoString Technologies Inc. Obtains CE Mark for PAM50-Based Test for Breast Cancer

  September 27, 2012

   · 

  4 min read
• Drug Development

  XOMA (US) LLC Announces Servier Has Initiated Phase 3 Gevokizumab Trial in Patients With Behcet’s Uveitis

  September 27, 2012

   · 

  1 min read
• BioCapital

  Optics Express Release: Cyborg Surgeon: Hand and Technology Combine in New Surgical Tool That Enables Superhuman Precision

  September 27, 2012

   · 

  1 min read
• BioCapital

  MPEG LA’s Librassay® Removes Patent Barriers to Diagnostics for Personalized Medicine

  September 27, 2012

   · 

  6 min read
• Job Trends

  VLST Corp. Cuts Scientific Group as Focus Shifts to Clinical Trials

  September 27, 2012

   · 

  1 min read
• FDA

  Kelyniam Global Receives FDA 501(k) Approval for Custom Craniofacial Implants

  September 27, 2012

   · 

  2 min read
• Business

  Ablynx Proposes to Strengthen Its Board With the Appointment of Dr Roger Perlmutter and Dr Russell Greig

  September 27, 2012

   · 

  3 min read
• Business

  Advanced BioScience Laboratories, Inc. Awards Avid Bioservices, Inc. HIV Vaccine Development and Manufacturing Contract

  September 27, 2012

   · 

  3 min read
• Policy

  Hemispherx Biopharma’s Ampligen Rehash Unlikely to Impress FDA

  September 27, 2012

   · 

  1 min read
• Drug Development

  Radius Initiates Phase 2 Study of BA058-Transdermal for the Treatment of Postmenopausal Osteoporosis

  September 27, 2012

   · 

  5 min read